Novel Predictors of Outcome in Hypertrophic Cardiomyopathy
Protected: Ancillary Studies
The HCMR study is well under way, with the first participant enrolled in April 2014 at research site 001. There are now 44 active sites; 22 sites in North America and 22 sites in Europe. The study is now following up the 2750 patients that were enrolled and is no longer recruiting.